Nutrients, Vol. 17, Pages 3875: Metabolic and Neuroenergetic Effects of Intranasal Vitamin C Application in the Human Brain

Nutrients doi: 10.3390/nu17243875

Authors:
Lena-Christin Ingwersen
Alina Kistenmacher
Uwe H. Melchert
Kerstin M. Oltmanns

Background: Compared with normal weight, obese individuals display a variety of deviant measures in neuroenergetic status, food intake behavior, glucose metabolism, and circulating vitamin C levels. A chronically lowered neuroenergetic content is associated with increased food intake and disturbed glucose metabolism in obesity. In turn, a vitamin C deficiency found in obesity may be connected to these disturbances. Therefore, we investigated the effects of vitamin C application in the human brain. Methods: We intranasally applied vitamin C (80 mg ascorbic acid/day) vs. placebo for 8 consecutive days in 15 normal weight (BMI 20–25 kg/m2) and 15 obese (BMI > 30 kg/m2) men. The neuroenergetic content of adenosine triphosphate (ATP) and phosphocreatine (PCr) was assessed by 31phosphorous magnetic resonance spectroscopy, a non-invasive real-time technique to measure high-energy phosphate compounds in living tissues. Peripheral vitamin C, glucose, and insulin concentrations were measured, and spontaneous food intake was quantified by the standardized buffet test. Results: In the obese group, vitamin C application acutely suppressed the physiological insulin response on the first experimental day (p = 0.003). The following eight days of intranasal vitamin C led to higher serum vitamin C concentrations as compared to placebo (p = 0.011), compensated for the missing food intake-induced serum vitamin C rise (p ≤ 0.002), and attenuated a PCr decline (p = 0.008) in this group. Correlation analyses revealed a general link between serum vitamin C concentrations and the neuroenergetic state in both groups (p ≤ 0.033). Food intake was not influenced. Conclusions: Intranasal vitamin C application acutely improves insulin sensitivity, compensates for a vitamin C deficiency, and may act in a neuroprotective way in obese men. It could therefore be a future candidate as an adjuvant therapeutic option in obesity treatment.

Source link

Lena-Christin Ingwersen www.mdpi.com